Table 3.
Levels of bone turnover markers in patients with PMOP and healthy controls
| Control (n = 37) | PMOP (n = 56) | P‐Value | |
|---|---|---|---|
| T‐score | −1.50 ± 0.75 | −3.28 ± 0.59 | .000 |
| BMD (g/cm2） | 0.87 ± 0.11 | 0.67 ± 0.09 | .000 |
| PINP (ng/mL) | 43.93 ± 18.71 | 61.88 ± 21.11 | .001 |
| CROSSL (ng/mL) | 0.66 ± 0.31 | 0.91 ± 0.44 | .019 |
| OSTEOC (ng/mL) | 15.75 ± 6.20 | 20.19 ± 9.36 | .028 |
Abbreviations: BMD, bone mineral density; CROSSL, β‐crosslaps; OSTEOC, osteocalcin; PINP, procollagen type 1 N‐terminal propeptide; PMOP, postmenopausal osteoporosis.